{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:04:12Z","timestamp":1761419052314,"version":"3.37.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T00:00:00Z","timestamp":1464566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11897-016-0288-6","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T07:36:55Z","timestamp":1464593815000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient"],"prefix":"10.1007","volume":"13","author":[{"given":"Christopher W.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew B.","family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Joseph","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"288_CR1","doi-asserted-by":"crossref","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. Elsevier Inc.; 2013;62:D42\u201350. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.jacc.2013.10.032 .","DOI":"10.1016\/j.jacc.2013.10.032"},{"key":"288_CR2","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali","year":"2009","unstructured":"Gali N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30:2493\u2013537.","journal-title":"Eur Heart J"},{"key":"288_CR3","doi-asserted-by":"crossref","unstructured":"Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. Am Coll Cardiol Found. 2009;54:S67\u201377. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.jacc.2009.04.016 .","DOI":"10.1016\/j.jacc.2009.04.016"},{"key":"288_CR4","doi-asserted-by":"crossref","unstructured":"Schaffer JM, Singh SK, Joyce DL, Reitz BA, Robbins RC, Zamanian RT, et al. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. Circulation. 2013;127:2503\u201313. Available from: http:\/\/circ.ahajournals.org.laneproxy.stanford.edu\/content\/127\/25\/2503","DOI":"10.1161\/CIRCULATIONAHA.112.001080"},{"key":"288_CR5","doi-asserted-by":"crossref","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med. 2001;345:1435\u201343. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11794191","DOI":"10.1056\/NEJMoa012175"},{"key":"288_CR6","doi-asserted-by":"crossref","unstructured":"Costanzo MR, Augustine S, Bourge R, Bristow M, O\u2019Connell JB, Driscoll D, et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593\u2013612. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8521589","DOI":"10.1161\/01.CIR.92.12.3593"},{"key":"288_CR7","doi-asserted-by":"crossref","unstructured":"Delgado JF, G\u00f3mez-S\u00e1nchez MA, S\u00e1enz de la Calzada C, S\u00e1nchez V, Escribano P, Hern\u00e1ndez-Afonso J, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J. Heart Lung Transplant. 2001;20:942\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11557188 .","DOI":"10.1016\/S1053-2498(01)00286-8"},{"key":"288_CR8","doi-asserted-by":"crossref","unstructured":"Kirklin JK, Naftel DC, Bourge RC, McGiffin DC, Hill JA, Rodeheffer RJ, et al. Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. J. Thorac. Cardiovasc. Surg. 2003;125:881\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12698152 .","DOI":"10.1067\/mtc.2003.168"},{"key":"288_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","volume":"31","author":"D Zimpfer","year":"2007","unstructured":"Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, Zuckermann A, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardio Thorac Surg. 2007;31:698\u2013702.","journal-title":"Eur J Cardio Thorac Surg"},{"key":"288_CR10","doi-asserted-by":"crossref","unstructured":"Butler J, Stankewicz M a., Wu J, Chomsky DB, Howser RL, Khadim G, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J. Hear. Lung Transplant. 2005;24:170\u20137. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249803009793 .","DOI":"10.1016\/j.healun.2003.09.045"},{"key":"288_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","volume":"19","author":"A Costard-J\u00e4ckle","year":"1992","unstructured":"Costard-J\u00e4ckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"288_CR12","doi-asserted-by":"crossref","unstructured":"Miller WL, Mahoney DW, Michelena HI, Pislaru S V, Topilsky Y, Enriquez-Sarano M. Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure. JACC. Cardiovasc. Imaging 2011;4:946\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21920331 .","DOI":"10.1016\/j.jcmg.2011.06.017"},{"key":"288_CR13","doi-asserted-by":"crossref","unstructured":"Szwejkowski BR, Elder DHJ, Shearer F, Jack D, Choy AMJ, Pringle SD, et al. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. Eur J Heart Fail. 2012;14:162\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22178623 .","DOI":"10.1093\/eurjhf\/hfr159"},{"key":"288_CR14","doi-asserted-by":"crossref","unstructured":"Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC. Heart Fail. 2013;1:290\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24621932 .","DOI":"10.1016\/j.jchf.2013.05.001"},{"key":"288_CR15","doi-asserted-by":"crossref","unstructured":"Cappola TP, Felker GM, Kao WHL, Hare JM, Baughman KL, Kasper EK. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002;105:1663\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11940544 .","DOI":"10.1161\/01.CIR.0000013771.30198.82"},{"key":"288_CR16","doi-asserted-by":"crossref","unstructured":"Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999;34:1802\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10577573 .","DOI":"10.1016\/S0735-1097(99)00408-8"},{"key":"288_CR17","doi-asserted-by":"crossref","unstructured":"Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, Lehmkuhl HB, et al. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg. 2011;40:971\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21354812 .","DOI":"10.1016\/j.ejcts.2011.01.019"},{"key":"288_CR18","doi-asserted-by":"crossref","unstructured":"Pauwaa S, Bhat G, Tatooles AJ, Aggarwal A, Martin M, Kumar A, et al. How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates?. Cardiol J. 2012;19:153\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22461048 .","DOI":"10.5603\/CJ.2012.0027"},{"key":"288_CR19","doi-asserted-by":"crossref","unstructured":"Alba AC, Rao V, Ross HJ, Jensen AS, Sander K, Gustafsson F, et al. Impact of fixed pulmonary hypertension on postheart transplant outcomes in bridge-to-transplant patients. J. Hear. Lung Transplant. Elsevier Inc., 2010;29:1253\u20138. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.healun.2010.06.002 .","DOI":"10.1016\/j.healun.2010.06.002"},{"key":"288_CR20","doi-asserted-by":"crossref","unstructured":"Thenappan T, Gomberg-maitland M. Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure. Curr Heart Fail Rep. 2014;428\u201335","DOI":"10.1007\/s11897-014-0216-6"},{"key":"288_CR21","doi-asserted-by":"crossref","unstructured":"Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1\u20136. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1053249805004973 .","DOI":"10.1016\/j.healun.2005.07.008"},{"key":"288_CR22","doi-asserted-by":"crossref","unstructured":"Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg. 2008;86:832\u201340; discussion 832\u201340. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003497508010163 .","DOI":"10.1016\/j.athoracsur.2008.05.016"},{"key":"288_CR23","doi-asserted-by":"crossref","unstructured":"Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 51:2163\u201372. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109708010280 .","DOI":"10.1016\/j.jacc.2008.03.009"},{"key":"288_CR24","doi-asserted-by":"crossref","unstructured":"Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc. Surg. 2010;139:1316\u201324. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022522309014755 .","DOI":"10.1016\/j.jtcvs.2009.11.020"},{"key":"288_CR25","doi-asserted-by":"crossref","unstructured":"Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, et al. Right heart failure and \u201cfailure to thrive\u201d after left ventricular assist device: clinical predictors and outcomes. J. Heart Lung Transplant. 2011;30:888\u201395. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1053249811008680 .","DOI":"10.1016\/j.healun.2011.03.006"},{"key":"288_CR26","doi-asserted-by":"crossref","unstructured":"Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report\u20142005. J Heart Lung Transplant. 2005;24:1182\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16143231 .","DOI":"10.1016\/j.healun.2005.07.002"},{"key":"288_CR27","doi-asserted-by":"crossref","unstructured":"Santambrogio L. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact. Cardiovasc. Thorac. Surg. 2006;5:379\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17670597 .","DOI":"10.1510\/icvts.2006.128322"},{"key":"288_CR28","doi-asserted-by":"crossref","unstructured":"Farrar DJ, Hill JD, Pennington DG, McBride LR, Holman WL, Kormos RL, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg. 1997;113:202\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9011691 .","DOI":"10.1016\/S0022-5223(97)70416-1"},{"key":"288_CR29","doi-asserted-by":"crossref","unstructured":"Kormos RL, Gasior TA, Kawai A, Pham SM, Murali S, Hattler BG, et al. Transplant candidate\u2019s clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J. Thorac. Cardiovasc. Surg. 1996;111:773\u201382. Discussion 782\u20133. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8614137 .","DOI":"10.1016\/S0022-5223(96)70337-9"},{"key":"288_CR30","doi-asserted-by":"crossref","unstructured":"Fitzpatrick JR, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971\u20137. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022522308015638 .","DOI":"10.1016\/j.jtcvs.2008.09.021"},{"key":"288_CR31","doi-asserted-by":"crossref","unstructured":"Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann. Surg. 1995;222:327\u201336; discussion 336\u20138. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=1234813&tool=pmcentrez&rendertype=abstract","DOI":"10.1097\/00000658-199509000-00010"},{"key":"288_CR32","doi-asserted-by":"crossref","unstructured":"Fitzpatrick JR, Frederick JR, Hsu VM, Kozin ED, O\u2019Hara M Lou, Howell E, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J. Heart Lung Transplant. Int Soc Heart Lung Transplant. 2008;27:1286\u201392. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3235680&tool=pmcentrez&rendertype=abstract .","DOI":"10.1016\/j.healun.2008.09.006"},{"key":"288_CR33","doi-asserted-by":"crossref","unstructured":"Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, et al. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. Elsevier Inc.; 2013;96:857\u201363; discussion 863\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23791165 .","DOI":"10.1016\/j.athoracsur.2013.03.099"},{"key":"288_CR34","doi-asserted-by":"crossref","unstructured":"Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. Elsevier Inc., 2010;105:1030\u20135. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914909027404 .","DOI":"10.1016\/j.amjcard.2009.11.026"},{"key":"288_CR35","doi-asserted-by":"crossref","unstructured":"Raina A, Seetha Rammohan HR, Gertz ZM, Rame JE, Woo YJ, Kirkpatrick JN. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters. J Card Fail. Elsevier Inc.; 2013;19:16\u201324. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.cardfail.2012.11.001 .","DOI":"10.1016\/j.cardfail.2012.11.001"},{"key":"288_CR36","doi-asserted-by":"crossref","unstructured":"Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106:I198\u2013202. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12354733 .","DOI":"10.1161\/01.cir.0000032906.33237.1c"},{"key":"288_CR37","doi-asserted-by":"crossref","unstructured":"Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999;68:2181\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10616999 .","DOI":"10.1016\/S0003-4975(99)00753-5"},{"key":"288_CR38","doi-asserted-by":"crossref","unstructured":"Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J. Hear. Lung Transplant. Elsevier; 2015;34:1123\u201330. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249815013376 .","DOI":"10.1016\/j.healun.2015.06.015"},{"key":"288_CR39","doi-asserted-by":"crossref","unstructured":"Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score. J Am Coll Cardiol. 2008;51:2163\u201372. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109708010280","DOI":"10.1016\/j.jacc.2008.03.009"},{"key":"288_CR40","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2015;ehv317. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26320113 ."},{"key":"288_CR41","doi-asserted-by":"crossref","unstructured":"Cheli M, Vachiery JL. Controversies in pulmonary hypertension due to left heart disease. F1000Prime Rep. 2015;7. Available from: http:\/\/f1000.com\/prime\/reports\/m\/7\/7 .","DOI":"10.12703\/P7-07"},{"key":"288_CR42","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Corris P a., Frost A, Girgis RE, Granton J, Jing ZC, et al. Updated treatment algorithm of pulmonary arterial hypertension. J. Am. Coll. Cardiol. Elsevier Inc.; 2013;62:D60\u201372. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.jacc.2013.10.031 .","DOI":"10.1016\/j.jacc.2013.10.031"},{"key":"288_CR43","doi-asserted-by":"crossref","unstructured":"Jing Z-C, Jiang X, Han Z-Y, Xu X-Q, Wang Y, Wu Y, et al. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;33:1354\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19213781 .","DOI":"10.1183\/09031936.00169608"},{"key":"288_CR44","doi-asserted-by":"crossref","unstructured":"Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, Levin HR, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 1998;65:340\u20135. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003497597013076 .","DOI":"10.1016\/S0003-4975(97)01307-6"},{"key":"288_CR45","doi-asserted-by":"crossref","unstructured":"Antoniou T, Prokakis C, Athanasopoulos G, Thanopoulos A, Rellia P, Zarkalis D, et al. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction. Ann Thorac Surg. 2012;94:792\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22727248 .","DOI":"10.1016\/j.athoracsur.2012.04.046"},{"key":"288_CR46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.athoracsur.2006.08.051","volume":"83","author":"CT Klodell","year":"2007","unstructured":"Klodell CT, Morey TE, Lobato EB, Aranda JM, Staples ED, Schofield RS, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg. 2007;83:68\u201371. discussion 71.","journal-title":"Ann Thorac Surg"},{"key":"288_CR47","doi-asserted-by":"crossref","unstructured":"Hamdan R, Mansour H, Nassar P, Saab M. Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor. Artif Organs. 2014","DOI":"10.1111\/aor.12277"},{"key":"288_CR48","unstructured":"Wagner F, Dandel M, G\u00fcnther G, Loebe M, Schulze-Neick I, Laucke U, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation. 1997;96:II \u2013 291\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9386113 ."},{"key":"288_CR49","unstructured":"Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet (London, England). 1991;338:1173\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1682593 ."},{"key":"288_CR50","doi-asserted-by":"crossref","unstructured":"Ichinose F, Roberts JD, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004;109:3106\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15226227 .","DOI":"10.1161\/01.CIR.0000134595.80170.62"},{"key":"288_CR51","doi-asserted-by":"crossref","unstructured":"Dehne MG, D SGP, Hentschel T. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Cardiothorac Anesth Respir Airw. 2002;1076\u201380.","DOI":"10.1007\/BF03017906"},{"key":"288_CR52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11897-012-0106-8","volume":"9","author":"M Guazzi","year":"2012","unstructured":"Guazzi M, Castelvecchio S, Bandera F, Menicanti L. Right ventricular pulmonary hypertension. Curr Heart Fail Rep. 2012;9:303\u20138.","journal-title":"Curr Heart Fail Rep"},{"key":"288_CR53","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College. Circulation. 2009;119:2250\u201394.","journal-title":"Circulation"},{"key":"288_CR54","doi-asserted-by":"crossref","unstructured":"Sastry BKS, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43:1149\u201353. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109704001056 .","DOI":"10.1016\/j.jacc.2003.10.056"},{"key":"288_CR55","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med. [Internet]. 2005 [cited 2016 Apr 27];353:2148\u201357. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16291984","DOI":"10.1056\/NEJMoa050010"},{"key":"288_CR56","doi-asserted-by":"crossref","unstructured":"Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006;151:851.e1\u20135. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002870305008513 .","DOI":"10.1016\/j.ahj.2005.09.006"},{"key":"288_CR57","doi-asserted-by":"crossref","unstructured":"Simonneau G. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension. Ann. Intern. Med. Am Coll Phys. 2008;149:521. Available from: http:\/\/annals.org\/article.aspx?articleid=743198 .","DOI":"10.7326\/0003-4819-149-8-200810210-00004"},{"key":"288_CR58","doi-asserted-by":"crossref","unstructured":"McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;174:1257\u201363. Available from: http:\/\/www.atsjournals.org\/doi\/abs\/ 10.1164\/rccm.200603-358OC .","DOI":"10.1164\/rccm.200603-358OC"},{"key":"288_CR59","doi-asserted-by":"crossref","unstructured":"Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. 2002;22:746\u201352.","DOI":"10.1016\/S1010-7940(02)00488-8"},{"key":"288_CR60","doi-asserted-by":"crossref","unstructured":"Kutty RS, Parameshwar J, Lewis C, Catarino PA, Sudarshan CD, Jenkins DP, et al. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2013;43:1237\u201342. Available from: http:\/\/ejcts.oxfordjournals.org.ezproxy.stanford.edu\/content\/43\/6\/1237 .","DOI":"10.1093\/ejcts\/ezs678"},{"key":"288_CR61","doi-asserted-by":"crossref","unstructured":"Sitbon O, Humbert M, Ja\u00efs X, Ioos V, Hamid AM, Provencher S, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111:3105\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15939821 .","DOI":"10.1161\/CIRCULATIONAHA.104.488486"},{"key":"288_CR62","doi-asserted-by":"crossref","unstructured":"Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134:44\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9266782 .","DOI":"10.1016\/S0002-8703(97)70105-4"},{"key":"288_CR63","doi-asserted-by":"crossref","unstructured":"Haglund NA, Burdorf A, Jones T, Shostrom V, Um J, Ryan T, et al. Inhaled milrinone after left ventricular assist device implantation. J. Card. Fail. 2015. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S107191641500113X .","DOI":"10.1016\/j.cardfail.2015.04.011"},{"key":"288_CR64","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","volume":"83","author":"CD Etz","year":"2007","unstructured":"Etz CD, Welp HA, Tjan TDT, Hoffmeier A, Weigang E, Scheld HH, et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg. 2007;83:1697\u2013705.","journal-title":"Ann. Thorac. Surg."},{"key":"288_CR65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s380-002-8320-z","volume":"16","author":"S Kihara","year":"2002","unstructured":"Kihara S, Kawai A, Fukuda T, Yamamoto N, Aomi S, Nishida H, et al. Effects of milrinone for right ventricular failure after left ventricular assist device implantation. Heart Vessels. 2002;16:69\u201371.","journal-title":"Heart Vessels"},{"key":"288_CR66","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jocs.12214","volume":"28","author":"P Atluri","year":"2013","unstructured":"Atluri P, Fairman AS, Macarthur JW, Goldstone AB, Cohen JE, Howard JL, et al. Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. J Card Surg. 2013;28:770\u20135.","journal-title":"J Card Surg"},{"key":"288_CR67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jtcvs.2005.09.031","volume":"131","author":"S Schenk","year":"2006","unstructured":"Schenk S, McCarthy PM, Blackstone EH, Feng J, Starling RC, Navia JL, et al. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg. 2006;131:447\u201354.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"288_CR68","doi-asserted-by":"crossref","unstructured":"Potapov E V, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J. Heart Lung Transplant. Int Soc Heart Lung Transplant. 2008;27:1275\u201381. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19059106 .","DOI":"10.1016\/j.healun.2008.08.012"},{"key":"288_CR69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCHEARTFAILURE.108.796789","volume":"1","author":"RJ Tedford","year":"2008","unstructured":"Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213\u20139.","journal-title":"Circ Heart Fail"},{"key":"288_CR70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10047-012-0662-4","volume":"16","author":"T Imamura","year":"2013","unstructured":"Imamura T, Kinugawa K, Hatano M, Kato N, Minatsuki S, Muraoka H, et al. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device. J Artif Organs. 2013;16:101\u20134.","journal-title":"J Artif Organs"},{"key":"288_CR71","doi-asserted-by":"crossref","unstructured":"LaRue SJ, Garcia-Cortes R, Nassif ME, Vader JM, Ray S, Ravichandran A, et al. Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation. Cardiovasc Ther. 2015;33:50\u20135. Available from: http:\/\/doi.wiley.com\/ 10.1111\/1755-5922.12111 .","DOI":"10.1111\/1755-5922.12111"},{"key":"288_CR72","doi-asserted-by":"crossref","unstructured":"Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation. 2007;116:238\u201348. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17606845 .","DOI":"10.1161\/CIRCULATIONAHA.106.655266"},{"key":"288_CR73","doi-asserted-by":"crossref","unstructured":"Zamanian RT, Kudelko KT, Sung YK, de Jesus Perez V, Liu J, Spiekerkoetter E. Current clinical management of pulmonary arterial hypertension. Circ Res. 2014;115:131\u201347. Available from: http:\/\/circres.ahajournals.org\/content\/115\/1\/131.long .","DOI":"10.1161\/CIRCRESAHA.115.303827"},{"key":"288_CR74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000355875","volume":"92","author":"M Padeletti","year":"2013","unstructured":"Padeletti M, Caputo M, Zaca V, Tsioulpas C, Bernazzali S, Mondillo S, et al. Effect of bosentan on pulmonary hypertension secondary to systolic heart failure. Pharmacology. 2013;92:281\u20135.","journal-title":"Pharmacology"},{"key":"288_CR75","doi-asserted-by":"crossref","unstructured":"Ghofrani H-A, D\u2019Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319\u201329. Available from: http:\/\/www.nejm.org\/doi\/abs\/ 10.1056\/NEJMoa1209657 .","DOI":"10.1056\/NEJMoa1209657"},{"key":"288_CR76","doi-asserted-by":"crossref","unstructured":"Bonderman D, Ghio S, Felix SB, Ghofrani H-A, Michelakis E, Mitrovic V, et al. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation. 2013;128:502\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23775260 .","DOI":"10.1161\/CIRCULATIONAHA.113.001458"},{"key":"288_CR77","doi-asserted-by":"crossref","unstructured":"Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C, et al. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. Chest. 2014;146:1274\u201385. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4219342&tool=pmcentrez&rendertype=abstract .","DOI":"10.1378\/chest.14-0106"},{"key":"288_CR78","doi-asserted-by":"crossref","unstructured":"Lampert B, Weaver S, Scanlon a., Lockard K, Allen C, Kunz N, et al. 734 blood pressure control in continuous flow left ventricular assist devices\u2014efficacy and impact on adverse events. J Hear Lung Transplant. Elsevier Inc.; 2012;31:S251. Available from: http:\/\/dx.doi.org\/ 10.1016\/j.athoracsur.2013.07.069 .","DOI":"10.1016\/j.healun.2012.01.750"},{"key":"288_CR79","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-116-11-888","volume":"116","author":"SV Abramson","year":"1992","unstructured":"Abramson SV, Burke JF, Kelly JJJ. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 1992;116:888\u201395.","journal-title":"Ann Intern Med"},{"key":"288_CR80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","volume":"37","author":"S Ghio","year":"2001","unstructured":"Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"288_CR81","doi-asserted-by":"crossref","unstructured":"Kalogeropoulos AP, Siwamogsatham S, Hayek S, Li S, Deka A, Marti CN, et al. Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients. J Am Heart Assoc. 2014;3:e000363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24492947 .","DOI":"10.1161\/JAHA.113.000363"},{"key":"288_CR82","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2004.07.013","volume":"24","author":"PP Chang","year":"2005","unstructured":"Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, et al. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005;24:998\u20131007.","journal-title":"J Heart Lung Transplant"},{"key":"288_CR83","doi-asserted-by":"crossref","unstructured":"Tatebe S, Fukumoto Y, Sugimura K, Miyamichi-Yamamoto S, Aoki T, Miura Y, et al. Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. Circ J. 2012;76:1235\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22313804","DOI":"10.1253\/circj.CJ-11-1288"},{"key":"288_CR84","doi-asserted-by":"crossref","unstructured":"Tsukashita M, Takayama H, Takeda K, Han J, Colombo PC, Yuzefpolskaya M, et al. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg. [Internet]. Elsevier Inc.; 2015; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522315012222 .","DOI":"10.1016\/j.jtcvs.2015.07.012"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-016-0288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-016-0288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-016-0288-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:34:38Z","timestamp":1692380078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-016-0288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s11897-016-0288-6","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"type":"print","value":"1546-9530"},{"type":"electronic","value":"1546-9549"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}